← All organizations

Regulus Therapeutics Inc.

For profitWebsite ↗

Also known as: Regulus Therapeutics | Regulus Therapeutics Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 6, 2022

Acquired by Novartis on Apr 30, 2025

Timeline

2000s

Sep 1, 2007
Regulus Therapeutics Inc.— Founded

2020s

Apr 30, 2025
Novartis— Acquired By

Drugs by trial phase (3 distinct, 5 trials)

Phase 2 (1 own, 0 via acquisition)

rg-012

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (9)

NCT05521191Lead sponsorPhase 1Oct 6, 2022
NCT05521191Study directorPhase 1Oct 6, 2022
NCT05429073Lead sponsorPhase 1Jun 10, 2022
NCT05429073Study directorPhase 1Jun 10, 2022
NCT04536688Lead sponsorPhase 1Oct 31, 2020
NCT04536688Study directorPhase 1Oct 31, 2020
NCT03373786Lead sponsorPhase 1Nov 27, 2017
NCT03373786Study directorPhase 1Nov 27, 2017
NCT02855268Lead sponsorPhase 2Aug 1, 2016

Details

Founded: Carlsbad, CA, US Sep 1, 2007
Last known activity: Oct 6, 2022